Navigation Links
Genstruct Names Louis Latino VP of Sales
Date:9/17/2008

CAMBRIDGE, Mass., Sept. 17 /PRNewswire/ -- Genstruct Inc., a systems biology company focused on identifying molecular mechanisms, networks and biomarkers to better develop novel therapeutics and molecular diagnostics, announced today that it has appointed Louis Latino as VP of Sales. As part of Genstruct's executive management team, Mr. Latino will lead the company's global sales efforts, focusing on building the company's sales infrastructure to drive future growth.

In his role as VP of Sales, Mr. Latino will be responsible for managing and expanding partnerships with existing customers while leveraging the Genstruct platform to expand the company's consulting services and partnership business through the development of new partnerships and collaborations within the global biotechnology, pharmaceutical and related industries.

"Earlier this year we launched our Consulting Services division, and we have rapidly grown this business to the point that we need to build a world- class sales team to manage its growth. Lou Latino has both the experience and expertise we need to manage the growth of this business," said Keith O. Elliston, Ph.D., president and CEO of Genstruct. "He is ideally suited to extend the impact of the Genstruct platform throughout the life sciences sector. His wealth of management experience with early-stage companies and his outstanding sales record in the life sciences industry are the key qualities we need to expand our current partnerships and our customer base."

"Genstruct's Causal Network(TM) modeling platform has been vital to the development of safe and effective new drugs for our partners," said Mr. Latino. "As Genstruct's team of scientists and technology experts focus on new approaches to better understand and treat complex diseases, I see this as an opportunity to leverage the company's successes to broaden its impact across the industry."

Mr. Latino has nearly 30 years of senior sales management and direct sales experience. Prior to joining Genstruct, he was VP of North America, Life Sciences Sales and Support for Accelrys, Inc., a developer of a broad range of technologies, including computer-aided-molecular-design and scientific business intelligence software. He honed his life sciences expertise as VP of Worldwide Sales for Geneformatics and as a regional sales manager for Biosym Technologies. In both positions, he exceeded revenue goals and increased profitability for the respective companies, while enhancing the impact of their technologies.

Mr. Latino has also held senior sales positions with Superscape Group, Mitchell Management Systems and BIW Cable Systems. He earned his bachelor's degree in chemistry from Boston College.

About Genstruct

Founded in 2002, Genstruct is a systems biology company focused on elucidating the complexity of biology for the development of safe and effective therapeutics and molecular diagnostics. By developing Causal Network(TM) models for complex biological systems, Genstruct develops a deep molecular understanding of diseases and drug action, and designs mechanistic biomarkers and molecular diagnostics to facilitate drug development and personalized medicine. Genstruct's Consulting Services division engages in short-, mid- and long-term partnerships with top tier pharmaceutical and life sciences companies, to develop new therapeutics and mechanistic biomarkers in the areas of oncology, metabolic disorders, cardiovascular diseases and inflammation. Genstruct was awarded the Bio-IT World 2008 Best Practices Award in the Drug Discovery & Development category for its joint collaboration with Sirtris Pharmaceuticals (a GSK company). Genstruct is a privately held company based in Cambridge, Mass. For more information, please visit http://www.genstruct.com.

Genstruct and the Genstruct logo are registered trademarks and Molecular Epistemics, Knowledge Assembly, and Epistemics Engine are trademarks of Genstruct, Inc. All other trademarks or registered trademarks are properties of their respective owners.

Contact:

Karen Higgins

A & E Communications for Genstruct

(610) 831-5723

khiggins@aandecomm.com


'/>"/>
SOURCE Genstruct Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Genstruct and Sirtris Pharmaceuticals Win Bio-IT Worlds Best Practices Award
2. Genstructs Andrea Matthews Selected for Mass High Techs People to Watch Under 30
3. Genstruct CEO, Dr. Keith Elliston, Invited to Speak at Oncology Clinical Trial Summit
4. Wyeth Names Daniel J. McIntyre Vice President, Corporate Communications
5. Axial Biotech Names New VP of Reimbursement and Regulatory Affairs
6. Inc. Magazine Names Senior Whole Health the Number One Fastest-Growing Private Company in US
7. ThermoGenesis Names Tiffany Olson to Board of Directors
8. ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
9. eResearchTechnology Names New Chief Financial Officer
10. HistoRx Names Bill Sullivan Senior Vice President, Diagnostic Operations
11. The TPAA Names Mark Oelschlager President
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):